TNF and cutaneous mastocytosis: TNF-alpha is upregulated in CM, however, modulating levels of TNF-alpha through anti-TNF monoclonal antibody treatment did not increase survival in a trial with pediatric CM patients and was correlated with increased neurological sequelae (van Hensbroek et al., 1996).